Literature DB >> 8168815

Identification of allele-specific p22-phox mutations in a compound heterozygous patient with chronic granulomatous disease by mismatch PCR and restriction enzyme analysis.

J P Hossle1, M de Boer, R A Seger, D Roos.   

Abstract

A rare subgroup (approx. 5%) of all chronic granulomatous disease (CGD) patients suffers from mutations in the gene encoding the small p22-phox subunit of the flavocytochrome b558 heterodimer, the terminal redox component of the phagocyte NADPH oxidase. A male CGD patient with neutrophil granulocytes devoid of any spectrometrically detectable cytochrome b558 owing to autosomally inherited p22-phox deficiency (phenotype, A22-) is reported. The patient was identified as being compound heterozygous for two independent mutations of his p22-phox alleles. On the maternal allele a single base substitution (A186 to T) was found that predicts a nonconservative replacement of Glu 53 by Val. On his paternal p22-phox allele a G was found to be added to a G stretch between nucleotides G195 and G199 in the cDNA sequence. The resulting frame shift predicts an aberrant open reading frame, 16 amino acids longer than the normal p22-phox polypeptide. Genomic DNA was tested for the presence of the mutant allele by mismatch PCR (polymerase chain reaction). For this purpose, a single base mismatch was introduced at nucleotide position 189, leading to digestion of the normal allele by the restriction enzyme HinfI. The maternal allele was found to be present in 50% of the patient's DNA and in 50% of the DNA from his mother. The same mismatch PCR analysis with control DNA from 35 healthy individuals ruled out the possibility that the single base substitution (A186 to T) represents a common polymorphism. Inheritance of the second allelic mutation (G insertion) was verified by restriction enzyme analysis using BslI [CC(N)7GG] to digest PCR-amplified genomic DNA at the mutation site. PCR in combination with restriction enzyme analysis proved to be a powerful tool for verification of point mutations in the compound heterozygous CGD patient analyzed and may be used for prenatal diagnosis in this family.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168815     DOI: 10.1007/bf00201671

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.

Authors:  C A Parkos; M C Dinauer; L E Walker; R A Allen; A J Jesaitis; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Molecular abnormalities of a phosphoglycerate kinase variant generated by spontaneous mutation.

Authors:  M Maeda; E V Bawle; R Kulkarni; E Beutler; A Yoshida
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

3.  Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils.

Authors:  A J Verhoeven; B G Bolscher; L J Meerhof; R van Zwieten; J Keijer; R S Weening; D Roos
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes.

Authors:  M N Kuppuswamy; J W Hoffmann; C K Kasper; S G Spitzer; S L Groce; S P Bajaj
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

6.  Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease.

Authors:  M C Dinauer; E A Pierce; G A Bruns; J T Curnutte; S H Orkin
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 7.  Molecular basis of the autosomal recessive forms of chronic granulomatous disease.

Authors:  J T Curnutte
Journal:  Immunodefic Rev       Date:  1992

8.  Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease.

Authors:  M C Dinauer; E A Pierce; R W Erickson; T J Muhlebach; H Messner; S H Orkin; R A Seger; J T Curnutte
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

9.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

10.  Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox).

Authors:  M de Boer; A de Klein; J P Hossle; R Seger; L Corbeel; R S Weening; D Roos
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

View more
  2 in total

Review 1.  Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Jacinta Bustamante; Caroline Kannengiesser; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Baruch Wolach; Joachim Roesler; Harry L Malech; Steven M Holland; John I Gallin; Marie-José Stasia
Journal:  Blood Cells Mol Dis       Date:  2010-02-18       Impact factor: 3.039

Review 2.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.